Page last updated: 2024-08-23

moexiprilat and pd 98059

moexiprilat has been researched along with pd 98059 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grohé, C; Löbbert, K; Stimpel, M; van Eickels, M; Vetter, H1

Other Studies

1 other study(ies) available for moexiprilat and pd 98059

ArticleYear
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Flavonoids; Heart; Immunoblotting; Isoquinolines; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; STAT3 Transcription Factor; Tetrahydroisoquinolines; Tetrazoles; Time Factors; Trans-Activators

1999